Hongxing Li1, Daniel M George1, Ruurd L Jaarsma1, Xinzhan Mao1. 1. 1 Department of Orthopaedic Surgery, Central Hospital of Shaoyang, Shaoyang 422000, China ; 2 Department of Orthopaedics, School of Medicine, Flinders University, Adelaide, Australia ; 3 Department of Orthopaedics and Trauma, Flinders Medical Centre, Adelaide, Australia ; 4 Department of Orthopaedic Surgery, 2nd Xiangya Hospital, Changsha 410011, China.
Abstract
BACKGROUND: The purpose of this study was to investigate the prevalence of metabolic syndrome and its co-morbidities in patients with primary knee osteoarthritis and to assess if the severity of metabolic syndrome, and components, correlates with the severity of osteoarthritis symptoms. METHODS: A case controlled analysis of 70 patients with osteoarthritis compared to a control group of 81 patients. Each patient underwent clinical review including history, examination, and pathology tests. The case-group all had stage IV osteoarthritis as determined by radiographs and intra-operative assessment. In addition a visual analogue scale (VAS), Hospital for Special Surgery knee score (HSS), and Hamilton Depression scores were completed. RESULTS: The prevalence of hypertension, obesity, dyslipidemia and metabolic syndrome was significantly higher in the patients with osteoarthritis compared to the control group. There is a significant correlation between the degree of hypertension, the presence of dyslipidemia or hyperglycemia and the severity of osteoarthritis symptoms. Variables hypertension, low HDL-C levels, and the number of co-morbidities were all identified as risk factors for increased osteoarthritis symptoms. CONCLUSIONS: There is a correlation between the number of metabolic disorders, the severity of hypertension and severity of osteoarthritis symptoms. Hypertension and decreased HDL-cholesterol were positive risk factors for increased osteoarthritis symptomatology.
BACKGROUND: The purpose of this study was to investigate the prevalence of metabolic syndrome and its co-morbidities in patients with primary knee osteoarthritis and to assess if the severity of metabolic syndrome, and components, correlates with the severity of osteoarthritis symptoms. METHODS: A case controlled analysis of 70 patients with osteoarthritis compared to a control group of 81 patients. Each patient underwent clinical review including history, examination, and pathology tests. The case-group all had stage IV osteoarthritis as determined by radiographs and intra-operative assessment. In addition a visual analogue scale (VAS), Hospital for Special Surgery knee score (HSS), and Hamilton Depression scores were completed. RESULTS: The prevalence of hypertension, obesity, dyslipidemia and metabolic syndrome was significantly higher in the patients with osteoarthritis compared to the control group. There is a significant correlation between the degree of hypertension, the presence of dyslipidemia or hyperglycemia and the severity of osteoarthritis symptoms. Variables hypertension, low HDL-C levels, and the number of co-morbidities were all identified as risk factors for increased osteoarthritis symptoms. CONCLUSIONS: There is a correlation between the number of metabolic disorders, the severity of hypertension and severity of osteoarthritis symptoms. Hypertension and decreased HDL-cholesterol were positive risk factors for increased osteoarthritis symptomatology.
Authors: David S Jevsevar; Gregory Alexander Brown; Dina L Jones; Elizabeth G Matzkin; Paul A Manner; Pekka Mooar; John T Schousboe; Steven Stovitz; James O Sanders; Kevin J Bozic; Michael J Goldberg; William Robert Martin; Deborah S Cummins; Patrick Donnelly; Anne Woznica; Leeaht Gross Journal: J Bone Joint Surg Am Date: 2013-10-16 Impact factor: 5.284
Authors: Margreth Grotle; Kare B Hagen; Bard Natvig; Fredrik A Dahl; Tore K Kvien Journal: BMC Musculoskelet Disord Date: 2008-10-02 Impact factor: 2.362
Authors: Jeffrey B Driban; Grace H Lo; Charles B Eaton; Kate L Lapane; Michael Nevitt; William F Harvey; Charles E McCulloch; Timothy E McAlindon Journal: Ther Adv Musculoskelet Dis Date: 2016-08-24 Impact factor: 5.346
Authors: Aqeel M Alenazi; Sakher M Obaidat; Mohammed M Alshehri; Shaima Alothman; Corey Gray; Jason Rucker; Lemuel R Waitman; Patricia M Kluding Journal: Pain Med Date: 2020-05-01 Impact factor: 3.750
Authors: Angela V Bedenbaugh; Machaon Bonafede; Elizabeth H Marchlewicz; Vinson Lee; Jeyanesh Tambiah Journal: Clinicoecon Outcomes Res Date: 2021-05-21